WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SAGE

Based on 11 analysts offering 12 month price targets for Sage Therapeutics Inc.
Min Forecast
$14.00+8.61%
Avg Forecast
$21.46+66.45%
Max Forecast
$29.00+124.98%

Should I buy or sell SAGE stock?

Based on 11 analysts offering ratings for Sage Therapeutics Inc.
Hold
Strong Buy
2 analysts 18.18%
Buy
1 analysts 9.09%
Hold
7 analysts 63.64%
Sell
1 analysts 9.09%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SAGE stock forecasts and price targets.

SAGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-17
Bank of America
Bottom 15%
15
SellDowngrades$14.00+8.61%2024-04-17
JP Morgan
Bottom 15%
15
Strong BuyMaintains$29.00+124.98%2024-03-26
RBC Capital
Top 5%
96
HoldReiterates$26.00+101.71%2024-03-11
Morgan Stanley
Bottom 7%
7
HoldMaintains$22.00+70.67%2024-02-28
Stifel Nicolaus
Bottom 9%
9
HoldMaintains$20.00+55.16%2023-12-18

1 of 2

Forecast return on equity

Is SAGE forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is SAGE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SAGE revenue forecast

What is SAGE's revenue in the next 3 years based on estimates from 12 analysts?
Avg 1 year Forecast
$37.1M-57.09%
Avg 2 year Forecast
$162.5M+87.97%
Avg 3 year Forecast
$315.2M+264.58%
SAGE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SAGE revenue growth forecast

How is SAGE forecast to perform vs Biotechnology companies and vs the US market?
Company
52.97%
Industry
37.64%
Market
10.1%
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SAGE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAGE$12.89$21.46+66.45%Hold
TNGX$7.31$17.00+132.56%Strong Buy
RLAY$5.95$23.50+294.96%Strong Buy
PLRX$12.60$46.67+270.37%Buy
SPRY$8.21$18.50+125.33%Buy
View Top Biotech Stocks

Sage Therapeutics Stock Forecast FAQ

Is Sage Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: SAGE) stock is to Hold SAGE stock.

Out of 11 analysts, 2 (18.18%) are recommending SAGE as a Strong Buy, 1 (9.09%) are recommending SAGE as a Buy, 7 (63.64%) are recommending SAGE as a Hold, 1 (9.09%) are recommending SAGE as a Sell, and 0 (0%) are recommending SAGE as a Strong Sell.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.

What is SAGE's revenue growth forecast for 2024-2026?

(NASDAQ: SAGE) Sage Therapeutics's forecast annual revenue growth rate of 52.97% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Sage Therapeutics's revenue in 2024 is $86,455,000.On average, 12 Wall Street analysts forecast SAGE's revenue for 2024 to be $2,230,018,194, with the lowest SAGE revenue forecast at $849,908,554, and the highest SAGE revenue forecast at $4,821,758,431. On average, 12 Wall Street analysts forecast SAGE's revenue for 2025 to be $9,768,118,024, with the lowest SAGE revenue forecast at $2,137,994,857, and the highest SAGE revenue forecast at $31,780,208,618.

In 2026, SAGE is forecast to generate $18,945,387,316 in revenue, with the lowest revenue forecast at $2,102,531,911 and the highest revenue forecast at $63,100,000,013.

What is SAGE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SAGE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SAGE's Price Target?

According to 11 Wall Street analysts that have issued a 1 year SAGE price target, the average SAGE price target is $21.46, with the highest SAGE stock price forecast at $29.00 and the lowest SAGE stock price forecast at $14.00.

On average, Wall Street analysts predict that Sage Therapeutics's share price could reach $21.46 by Apr 18, 2025. The average Sage Therapeutics stock price prediction forecasts a potential upside of 66.45% from the current SAGE share price of $12.89.

What is SAGE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SAGE) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.